医学
糖尿病
多药
比尔斯标准
药方
观察研究
急诊医学
老年病科
儿科
内科学
精神科
药理学
内分泌学
作者
Francesç Formiga,Xavier Vidal,Antònia Agustí,David Chivite,Beatriz Rosón,Jordi Barbé,Alfonso López‐Soto,Olga H. Torres,Antonio Fernández-Moyano,Julia Alonso García,Nieves Ramírez‐Duque,Ashna Jose
摘要
Abstract Aims To assess inappropriate prescribing in older people with diabetes mellitus during the month prior to a hospitalization, using tools on potentially inappropriate medicines ( PIM s) and potential prescribing omissions ( PPO s) and comparing inappropriate prescribing in patients with without diabetes. Methods In an observational, prospective multicentric study, we assessed inappropriate prescribing in 672 patients aged 75 years and older during hospital admission. The Beers, Screening Tool of Older Person's Prescriptions ( STOPP ) and Screening Tool to Alert Doctors to Right Treatment ( START ) criteria and Assessing Care of Vulnerable Elders ( ACOVE ‐3) medicine quality indicators were used. We analysed demographic and clinical factors associated with inappropriate prescribing. Results Of 672 patients, 249 (mean age 82.4 years, 62.9% female) had a diagnosis of diabetes mellitus. The mean number of prescribing drugs per patient with diabetes was 12.6 (4.5) vs. 9.4 (4.3) in patients without diabetes ( P < 0.001). Of those patients with diabetes, 74.2% used 10 or more medications; 54.5% of patients with diabetes had at least one Beers‐listed PIM , 68.1% had at least one STOPP ‐listed PIM , 64.6% had at least one START ‐listed PPO and 62.8% had at least one ACOVE ‐3‐listed PPO . Except for the Beers criteria, these prevalences were significantly higher in patients with diabetes than in those without. After excluding diabetes‐related items from these tools, only STOPP ‐listed PIM s remained significantly higher among patients with diabetes ( P = 0.04). Conclusions Polypharmacy is common among older patients with diabetes mellitus. Inappropriate prescribing is higher in older patients with diabetes, even when diabetes‐related treatment is excluded from the inappropriate prescribing evaluation.
科研通智能强力驱动
Strongly Powered by AbleSci AI